Preliminary Program subject to change
TD000 Early Stage Venture Creation: New Prospects for Chemical Engineers, Part II
OverviewNew ventures promise to provide chemical engineers with an increasing level of alternative career options. In an era of competitive funding resources, university-sourced startups can financially benefit academic institutes whose research often provides the technology being commercialized. Established corporations also look to new ventures as a source of innovation. While new ventures present many opportunities for Academia, Industry, Government, and the workforce, their early-stage needs are particularly demanding with high levels of risk resulting in significant challenges for all participants. Papers in this session will focus on the conception, strategic collaboration, and early stage development of new ventures.
Primary SponsorTopical D: Developing Value Through Synergistic Collaboration (TD)

Chair

R. Michael Raab
Post Doctoral Student
Chemical Engineering
Massachusetts Institute of Technology
77 Massachusetts Avenue, B56-439
Cambridge, MA 02139
Phone Number: 617-258-0349
Email: rmraab@mit.edu

CoChair

David Putnam
Chemical and Biomolecular Engineering
Cornell University
120 Olin Hall
Ithaca, NY 14853
Phone Number: 607-255-4352
Email: dap43@cornell.edu
Welcoming Remarks
The Role of Competitive Intelligence in Biotech Start-Ups
Salvador Carlucci1, Anthony Page1 and David Finegold2, (1)HealthIQ, Orange, CA 92648, (2)Keck Graduate Institute of Applied Life Sciences, Claremont, CA 91711
Networks of Hub Scientists in Commercializing Science from Academia, with a Case Study on the Langer Lab
Eugene Chiu, Biomedical Enterprise Program, Harvard-MIT Health Sciences & Technology, MIT/Harvard Business School, C/O Professor Fiona Murray, 50 Memorial Drive E52-567, Cambridge, MA 02142, Fiona Murray, MIT Sloan School of Management, MIT, 50 Memorial Drive E52-567, Cambridge, MA 02142 and Robert Langer, Chemical Engineering/Health Sciences & Technology, MIT, 77 Massachusetts Avenue, Room E25-342, Cambridge, MA 02139-4307
Intermission
A New Business Strategy for Startup Biotechnology Firms
Todd C. Zion and Thomas M. Lancaster, SmartCells, Inc., 100 Cummings Center, Suite 419E, Beverly, MA 01915
Agrivida: the Development of an Early Stage Agricultural Biotechnology Company
Jeremy C. Johnson, Massachusetts Institute of Technology, 77 Mass Ave. 66-060, Cambridge, MA 02139, Karl Ruping, Agrivida, Inc., 411 Massachusetts Ave., B1, Cambridge, MA 02139, Humberto De la Vega, Agrivida Research Laboratories, Agrivida, Inc., 411 Massachusetts Ave, B1, Cambridge, MA 02139, Kyle L. Jensen, MIT, 66-264 MIT 77 Massachusetts Ave, Cambridge, MA 02139 and R. Michael Raab, Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, B56-439, Cambridge, MA 02139
New Enterprises for Socially Responsible Treatments
Jay D. Keasling, Chemical Engineering and Bioengineering, UC, Berkeley, 201 Gilman Hall, Berkeley, CA 94720-1462

Topical D - Developing Value through Synergistic Collaboration